Warmblood horses — including Hanoverians, Dutch Warmbloods (KWPN), Oldenburgs, Westphalians, Trakehners, and the broader European sport horse population — represent some of the highest-value insured horses in the American equine insurance market. Warmbloods competing at the Grand Prix level in dressage or jumping regularly carry insured values of $500,000 to several million dollars, and even moderately competitive sport horses frequently carry values that require formal appraisal and specialized underwriting. Understanding warmblood insurance means understanding the breed registry system, the performance evaluation culture, and the specific health considerations of horses bred for athletic power and scope.
Warmblood valuation is inseparable from the breed's registry performance evaluation system. Horses with favorable stallion licensing assessments, mares with elite breed survey scores, and horses with WBFSH-ranked competition records have documented value credentials that inform insurance appraisals. The European registry system — with its studbook inspections, performance tests, and licensing requirements — creates a paper trail of documented value that simplifies the appraisal process for well-credentialed horses while making it more complex for horses without formal evaluation documentation.
Warmblood health patterns create specific insurance considerations. Osteochondritis dissecans (OCD) — a developmental orthopedic disease that affects young warmbloods at high rates relative to other breeds — is frequently excluded at underwriting if identified on pre-purchase radiographs. Wobbler syndrome (cervical vertebral malformation), while not breed-exclusive, has a recognized association with large-framed warmbloods. The breed's large body mass relative to its joint structures creates loading concerns that can result in degenerative joint disease at younger ages than seen in lighter breeds.